RELMADA THERAPEUTICS INC's ticker is and the CUSIP is 75955J902. A total of 4 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | +666.7% | 7,900 | +464.3% | 0.00% | – |
| Q2 2023 | $3 | -78.6% | 1,400 | -77.8% | 0.00% | – |
| Q1 2023 | $14 | -97.5% | 6,300 | -96.1% | 0.00% | -100.0% |
| Q4 2022 | $563 | -100.0% | 161,600 | +35.8% | 0.00% | -80.0% |
| Q3 2022 | $4,405,000 | +51.6% | 119,000 | -22.2% | 0.01% | +66.7% |
| Q2 2022 | $2,905,000 | +52.3% | 153,000 | +116.4% | 0.00% | +50.0% |
| Q1 2022 | $1,908,000 | +8572.7% | 70,700 | +6970.0% | 0.00% | – |
| Q4 2021 | $22,000 | -93.7% | 1,000 | -90.4% | 0.00% | – |
| Q3 2021 | $349,000 | +5.1% | 10,400 | 0.0% | 0.00% | – |
| Q2 2021 | $332,000 | +68.5% | 10,400 | +18471.4% | 0.00% | – |
| Q1 2021 | $197,000 | +43.8% | 56 | +30.2% | 0.00% | – |
| Q4 2020 | $137,000 | -65.9% | 43 | -59.8% | 0.00% | -100.0% |
| Q3 2020 | $402,000 | +131.0% | 107 | +174.4% | 0.00% | – |
| Q2 2020 | $174,000 | +770.0% | 39 | +550.0% | 0.00% | – |
| Q1 2020 | $20,000 | -60.0% | 6 | -53.8% | 0.00% | – |
| Q4 2019 | $50,000 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 229 | $806,000 | 0.03% |
| SIMPLEX TRADING, LLC | 56 | $197,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 8,600 | $303,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |